Skip to main content

Metachromatic
leukodystrophy (MLD)

is a rare and progressive disease that if left
untreated can have catastrophic consequences1

Metachromatic
leukodystrophy (MLD)

is a rare and progressive disease that if left untreated can have catastrophic consequences1

Early diagnosis is the first line of
defense against the impacts of MLD2,3

Early diagnosis is the first line of defense against the impacts of MLD2,3

References: 1. Biffi A, Cesani M, Fumagalli F, et al. Metachromatic leukodystophy-mutation analysis provides further evidence of genotype-phenotype correlation. Clin Genet. 2008;74:349-357. 2. Wang RY, Bodamer OA, Watson MS, et al. Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Gen Med. 2011:13;457-484. 3. Fumagalli F, Calbi V, Natali Sora MG, et al. Lentiviral hematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomized, open-label, phase 1/2 trial and expanded access. Lancet. 2022;399:372-383.